Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

0(0%)

Results Posted

100%(5 trials)

Phase Distribution

Ph phase_3

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 3Large-scale testing

5(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 35 (100.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials

Showing 5 of 5

completedphase_3

Montelukast in Patients With Seasonal Allergic Rhinitis - Spring 2000 Study (MK-0476A-162)(COMPLETED)

NCT00979901

completedphase_3

A Study Investigating the Effect of Montelukast in Patients With Seasonal Allergic Rhinitis (MK-0476-192)(COMPLETED)

NCT00960141

Clinical Trials (5)

Showing 5 of 5 trials

NCT00979901Phase 3

Montelukast in Patients With Seasonal Allergic Rhinitis - Spring 2000 Study (MK-0476A-162)(COMPLETED)

Completed

NCT00963599Phase 3

Montelukast in Seasonal Allergic Rhinitis - Fall 1999 Study (0476A-117)

Completed

NCT00972738Phase 3

Montelukast in Seasonal Allergic Rhinitis - Spring 2001 Study (0476-235)

Completed

NCT00963469Phase 3

Montelukast in Seasonal Allergic Rhinitis: Fall 2001 Study (0476-240)

Completed

NCT00960141Phase 3

A Study Investigating the Effect of Montelukast in Patients With Seasonal Allergic Rhinitis (MK-0476-192)(COMPLETED)

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5